What is better Quixy or GeneXus? When scouting for the appropriate Application Development Software for your business our recommendation is that you examine the features, costs, along with other critical information regarding the product and vendor. Here, you can examine the parallels and disparities between Quixy (overall score at 8.7 and user satisfaction at 99%) and GeneXus (overall score at 8.0 and user satisfaction at 100%).
You can also check their unique details, such as tools, plans, pricing, conditions, etc. Moreover, analyze the terms thoroughly for information on hidden fees, including, setup cost, independent customer service, upgrade fees, storage fees, and others.
Our team put a lot of effort to review all popular Rapid Application Development Software - RAD solutions available out there, but among them these three caught our special attention: Microsoft PowerApps, Google App Maker, GitHub.
Quixy can integrate with any third-party system using API integration.
Languages Supported
English
Chinese
German
Hindi
Japanese
Spanish
French
Russian
Italian
Dutch
Portugese
Polish
Turkish
Swedish
Arabic
Prominent Clients
Zippr, NEC Technologies, NTrust
Available Devices
Windows
Linux
Android
iPhone/iPad
Mac
Web-based
Windows Mobile
Company Size
Small Business
Large Enterprises
Medium Business
Freelancers
Available Support
email
phone
live support
training
tickets
General Info
Offers businesses and end users with a no code platform and robust tools to build applications and programs for automating workflows and streamlining business operations. Even with zero coding skills, Quixy’s easy-to-use tools and user-friendly interface enables citizen developers to build applications without the help of IT professionals.
GeneXus’ SMB and enterprise pricing plan information is available only upon request. Please contact the vendor for details and determine the best package for your business.
GeneXus supports integrations with various systems, applications, and services which include the following:
IBM Bluemix
SAP HANA Cloud Platform
SAP Business One
Microsoft Azure
Amazon Web Services
Google Cloud Platform
Salesforce Sales Cloud
SharePoint
Magento
Oracle JD Edwards EnterpriseOne
NetSuite
Microsoft Dynamics AX
Languages Supported
English
Chinese
German
Hindi
Japanese
Spanish
French
Russian
Italian
Dutch
Portugese
Polish
Turkish
Swedish
Arabic
Prominent Clients
Canon, DHL, Mitsubishi
Available Devices
Windows
Linux
Android
iPhone/iPad
Mac
Web-based
Windows Mobile
Company Size
Small Business
Large Enterprises
Medium Business
Freelancers
Available Support
email
phone
live support
training
tickets
General Info
A cross-platform application development solution that permits development teams and enterprises to easily adapt to evolving technologies as they rapidly build corporate applications.
Both Quixy and GeneXus were tested by a group of reliable B2B experts who prepared a thorough examination of all important elements of each software. Their final rating was calculated using our unique SmartScore system which gives an individual partial score to every factor like: main features, customer support, mobile support, security, client satisfaction as well as reviews in other media. Here at FinancesOnline we realize useful features are not the only factor important to a business so we make sure we pay attention to all facets of a app before calculating its final score.
Page last modified
Why is FinancesOnline free?
FinancesOnline is available for free for all business professionals interested in an efficient way to find top-notch SaaS solutions. We are able to keep our service free of charge thanks to cooperation with some of the vendors, who are willing to pay us for traffic and sales opportunities provided by our website. Please note, that FinancesOnline lists all vendors, we’re not limited only to the ones that pay us, and all software providers have an equal opportunity to get featured in our rankings and comparisons, win awards, gather user reviews, all in our effort to give you reliable advice that will enable you to make well-informed purchase decisions.
